Pillar Biosciences
Pillar Biosciences is prized with its patent-pending targeted sequencing technology platform and a proprietary data analysis toolkit, which achieves high sensitivity and specificity with clinical samples. The platform provides a fast, simple and affordable targeted sequencing method for NGS-based oncology testing. The start-up has also released its beta version of Lung & Colon Cancer Somatic Mutation Panel and BRCA1 & BRCA2 Germline Mutation Panel to cancer centers and clinical testing companies in the US and China for validation studies. The company was founded in 2014 and is headquartered in Natick, Massachusetts.
Domain
pillar-biosciences.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$34.5M
Founded
2013
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Pillar Biosciences use?+
We have not yet detected technologies for Pillar Biosciences.
What industry is Pillar Biosciences in?+
Pillar Biosciences operates in the Biotechnology industry.
Where is Pillar Biosciences based?+
Pillar Biosciences is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026